S15 ferences were found in the percentages of the immune cell populations studied between these tissues, luminex analyses of fat-conditioned media revealed significantly higher concentrations of IL-6, TNFα, adipsin and adiponectin from IFP than Sc adipose tissue. Similar differences were found in adipocyte-conditioned media from these two adipose tissues. Moreover, a positive correlation between TNFα release from fat-conditioned medium and body mass index was found in IFP (r = 0.338, p = 0.046).
Purpose: Discoidin domain receptor 2 (DDR2) is a cell membrane tyrosine kinase receptor for native type II collagen. Results from this and other laboratories indicate that activation of DDR2 by the interaction of the receptor with native type II collagen induces matrix metalloproteinase 13 (MMP-13) and increases expression of the receptor itself in chondrocytes. Data from our studies also demonstrates that increased expression of MMP-13 is associated with elevated expression of DDR2 in human osteoarthritic (OA) cartilages and in knee and temporomandibular joints in mouse models of OA. Moreover, the reduction of Ddr2 expression attenuated the OA progression in the joints of the mouse models of OA. It is of interest to note that the pericellular matrix, which separates chondrocytes from the interterritorial matrix of mature articular cartilage, contains no type II collagen. We hypothesize, therefore, that at the very early stage of OA progression, depletion of proteoglycans in the extracellular matrix, and particularly the degradation of the pericellular matrix, exposes chondrocytes to type II collagen. As a consequence, DDR2 is activated to induce MMP-13 in chondrocytes. Methods: We used the tetracycline-inducible expression system (Tet-off) to overexpress DDR2 in mature articular cartilage of mouse knee joints under the control of the mouse cartilage oligomeric matrix protein gene promoter. Pregnant mice were treated with doxycycline and females with litters were continuously treated with doxycycline until weaning (4-week-old). Transgenic mice and their wild-type littermates were maintained with regular water and food and sacrificed at the ages of 8, 12 and 16 weeks, at which time the knee joints were collected. Serial paraffin sections of the knee joints were prepared (n=8/group/stage). Transgenic mice and wild-type littermates at 12 weeks of age were also subjected to microsurgery to cause destabilization of the media meniscus (DMM). Serial paraffin sections of the knee joints were prepared from mice at 2, 4, 8 and 12 weeks following the surgery (n=8/group/time point). Immunohistostaining was performed with polyclonal antibodies against DDR2 and Tet-Repressor protein (TetR). DDR2 mRNA was measured by real-time PCR. Joint morphology was examined by Safranin O/Fast green staining and evaluated by a modified Mankin scoring system. Results: Increased expression of DDR2 was detected in mature articular cartilages of knee joints from transgenic mice. The level of DDR2 mRNA was increased about 2.5-fold in transgenic mice, compared to the wild-type littermates. No OA pathologic change was observed in transgenic mice overexpressing DDR2 at any post-natal stage. However, upon challenge with DMM surgery, we found that the OA pathologic progression was accelerated in the knee joints of the DDR2-overexpressing transgenic mice. Conclusions: These results are consistent with our hypothesis that the pericellular matrix is a critical structure to prevent type II collagen from binding DDR2. In the case of our transgenic mice, although there was more DDR2, the receptors were separated from the type II collagen fibrils by the pericellular matrix in normal conditions. Thus, DDR2 was not activated and MMP-13 expression and activity were not induced in chondrocytes in the transgenic mouse knee joints. In contrast, the up-regulated expression of DDR2 accelerates OA progression caused by the DMM surgery. We conclude that DDR2 can accelerate OA progression, but cannot initiate articular cartilage degeneration, in the absence of biochemical or biomechanical disruption of the pericellular matrix. Purpose: The pathogenesis of osteoarthritis (OA) involves both bone and cartilage changes. Calcitonin is well-known for its inhibitory actions on osteoclasts and bone resorption. We investigated the effect of endogenous increased levels of salmon calcitonin (sCT) on the articular cartilage and subchondral bone, after destabilization of the medial meniscus (DMM) in normal and sCT over-expressing mice. Methods: Mice over-expressing sCT and wild-type littermates were used for the experiments. Genotyping was performed by measuring the circulating serum levels of sCT by ELISA. Northern Blot expression analysis was carried out to investigate the liver-specific expression. Non-decalcified plastic embedded vertebrae from mice of 6 and 12 month of age were used for histomophometric investigations. Serum samples were collected for osteocalcin measurements and urine for Dpd/creatinine measurements. For evaluation of cartilage and subchondral bone changes, forty-four 10 week old mice were divided into four groups and subjected to destabilization of the medial meniscus (DMM) or sham operation. After 7 weeks the study was terminated and the knee joints isolated for histological analysis by Safranin'O staining and biochemical markers were measured in fasting blood samples. The proteoglycan volume of the tibia and femur was quantitative assessed from histology sections by using the VisioPharm image technology. Individual pixels were labeled for multiple variables including bone, proteoglycans and bone marrow to create a working algorithm. Still images were taken of the knee joint histology sections and the images were processed and classified by masking the area of interest. The algorithm was then applied to the processed area for calculating proteoglycan loss. Results: Transgenic mice had >800 pg/mL serum sCT and wild-type mice had no detectable levels. Von Kossa staining revealed an increase in trabecular bone volume (BV/TV) of 100% after 6 month and 150% after 12 month in sCT mice when compared to controls (P<0.05). Trabecular number and thickness increased significantly in transgenic mice of both 6 and 12 months of age (P<0.05), and trabecular separation decreased (P<0.05). Osteoblasts number, bone formation rate and osteocalcin measurements was not affected in transgenic mice. Wild-type DMM operated mice had major damage to the articular cartilage, compared to DMM operated transgenic mice. In wild-type animals a 5-fold increase in the quantitative erosion index was observed after DMM, and the semi-quantitative OARSI score showed more than 400% (P<0.001) increase, compared to sham-operated wild-type. DMM operated transgenic mice were protected against cartilage erosion and showed a 65% and 64% (P<0.001) reduction, respectively, for the two histopathological evaluation methods, compared to DMM wildtype littermates. Preliminary quantitative analysis of proteoglycan loss revealed a trend towards sCT protection against cartilage erosion, with DMM operated WT mice showing a 40% increase in proteoglycan loose compared to WT sham, while DMM operated sCT mice showed a 20% reduction compared to sCT sham. DMM operated WT mice showed a 30% reduction in proteoglycans compared to sCT DMM. Conclusions: sCT over-expressing mice had higher bone volume compared to wild-type, and were protected against cartilage erosion compared to wild-type litter mate controls. This data suggest that increased levels of sCT may hamper the pathogenesis of OA however more studies are necessary to confirm these preliminary results. Purpose: Recent clinical studies in patients showed that ACL deficiency not only shifts tibiofemoral contact location but significantly increases the magnitude of cartilage contact deformation: from 10-20% compressive deformation in contralateral normal knees to 20-30% in ACL-deficient knees of the same patients. In addition, previous in vitro models have shown that mechanically injured cartilage cultured in the presence of inflammatory cytokines, known to be upregulated in human synovial fluid after joint injury, potentiates matrix catabolism. The purpose of this study was to examine whether increased loading after injury further exacerbates cartilage degradation using both in vitro and in vivo models.
MICE OVER-EXPRESSING SALMON CALCITONIN HAVE STRONGLY ATTENUATED BONE AND CARTILAGE CHANGES AFTER DESTABILIZATION

EFFECTS OF DYNAMIC LOADING ON INJURED ARTICULAR CARTILAGE IN
Methods:
In vitro studies: Bovine cartilage explants (3mm diam x 1mm thick disks) were subjected to a single radially-unconfined compression to 50% final strain at a velocity of 1 mm/second (100%/second strain rate). Explants were then incubated with TNF-α (10 ng/mL) and IL-6/sIL-6R (20/100 ng/mL) over 8 days. Intermittent dynamic compression was applied from days 2-8 (0.5 Hz haversine waveform, 1 hr on, 5 hr off, 4 times per day), with dynamic compression amplitude varying from 0-30%, n=6 disks per condition. In vivo studies: IACUC approval was given by Rush University. Ten week old C57Bl/6 male mice were subjected to a surgical Destabilization-Induced Joint Injury (DMM) model developed by Glasson et al., alone or in combination with TM running (14 days 15°incline, 32 cm/sec, 20 min per day, for 2 weeks starting on day 4 post-surgery). For DMM surgery, the anterior medial meniscotibial ligament was completely severed. Control mice were subjected to only cage activity. At 3 weeks post surgery, mice were euthanized and joints were stained with India Ink for gross observations or protein was extracted for Luminex (23-plex mouse cytokine kit), n=3 per condition. Statistics: Data were analyzed by ANOVA with Tukey post-hoc test, p<0.05. Luminex data were normalized to the total protein extracted per joint.
Results:
In vitro studies: Dynamic compression applied to bovine cartilage initially subjected to injury and cytokine treatment caused additional loss of matrix GAG that increased with dynamic compression amplitude in a dose-dependent manner (ANOVA, p<0.05). In vivo studies: C57Bl/6 mice developed marked cartilage roughening and lesions 18 days post DMM surgery on the medial aspects of the operated joint, and fibrotic remodeling along the tibial and femoral joint margins was readily detected. The DMM model alone resulted in significantly elevated levels of IL-1β, G-CSF, KC (mouse IL-8-related), and MCP-1 compared to controls. With DMM+TM, the extent of erosion near the patellar groove was much more severe on both the lateral and medial sides and was accompanied by an additional fibrous ingrowth from the margins. Along with the increased joint damage, DMM+TM resulted in significantly increased protein levels of G-CSF, IL-1β and KC (murine related IL-8) over controls; IL-9 and IFN-γ were significantly decreased compared to controls. RANTES was increased over DMM alone.
Conclusions:
In this study, we showed that dynamic compression further increases GAG loss from injured cartilage explants in a dose-dependent manner. Additionally, a murine mimic of knee joint injury followed by dynamic loading revealed significantly different levels of specific inflammatory cytokines that have been previously found in human synovial fluid post-injury. These results demonstrate the potential usefulness of these in vitro and in vivo models for studying the mechanisms underlying cartilage degradation following joint injury and for testing the effects of therapeutics to ameliorate this degradative response.
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HIF2A/NF-κB SIGNAL IN CHONDROCYTES CONTROLS EXTENSIVE STEPS OF OSTEOARTHRITIS DEVELOPMENT IN MICE AND HUMANS
A. Fukai, T. Saito, A. Mabuchi, T. Ikeda, F. Yano, S. Ohba, N. Nishida, T. Akune, N. Yoshimura, T. Nakagawa, K. Nakamura, K. Tokunaga, U.-i. Chung, H. Kawaguchi The ROAD Study Group, Faculty of Med., Univ. of Toky, Tokyo, Japan Purpose: Endochondral ossification is a crucial process not only for skeletal growth but also for osteoarthritis (OA) development. This process starts from chondrocyte hypertrophy characterized by type X collagen (COL10A1) expression, which is followed by cartilage degradation, vascularization, and osteogenesis. This study sought to identify the molecular mechanism that extensively controls these sequential steps in mice and humans. Methods: We performed screenings of transcription factors using chondrogenic ATDC5, OUMS27 and SW1353 cells transfected with luciferasereporter constructs containing the target promoters. For functional studies, we used stable lines of ATDC5 cells with retroviral overexpression of the genes, the dominant negative mutants, the siRNA, and the mutants at the oxygen-dependent hydroxylation residues. Promoter analyses were performed by luciferase assay, electrophoretic mobility shift assay, and chromatin immunoprecipitation assay using the chondrogenic cells above. An experimental OA model was created surgically by inducing instability in the knee joints of 8-week-old mice, and OA severity was quantified by the OARSI histopathology grade. Human joint cartilage was obtained as surgical specimens of total knee arthroplasty. Using a population-based cohort of the ROAD study, we searched for common SNPs with minor allele frequency >0.1 in the 1.5 kb 5'UTR of the human gene, and genotyped the SNP by RFLP. Results: A COL10A1 promoter assay identified hypoxia-inducible factor 2α (HIF2A) as the most potent transactivator among transcription factors expressed in chondrocytes. The HIF2A expression increased with chondrocyte differentiation in cultured ATDC5 cells and in the mouse limb cartilage,
